RSLSTEEPER adds doc@HOME as a natural extension for telehealth solutions

RSLSTEEPER, the largest supplier of Prosthetic and Orthotic patient care services in the UK, has teamed up with healthcare solutions provider, Docobo, to provide clients with doc@HOME, an integrated telehealth solution for the remote management of patients with chronic diseases or long term health conditions such as chronic heart failure, diabetes and hypertension.

Docobo is the leading UK telehealth organisation that designs, develops and manufactures products supporting the management of patients in their own homes.

The Docobo HealthHUB portable home monitor allows patients to record vital signs, symptoms, lifestyle and quality of life measures around the clock from any location. This information is then securely transferred to the doc@HOME clinical database that can be accessed by clinicians using a standard secure web browser, which provides a presentation of the patient's health diary and alert indicators.

Doc@HOME is a fully versatile system that can be configured to meet the health needs of individual patients; empower patients to participate in their care delivery, support their carers and reduce the burden of care provision through particular information required by clinicians to deliver expert care on a patient by patient basis. Commenting, Andrew Thornton, Managing Director of RSLSTEEPER, said: "doc@HOME is in widespread usage throughout the UK and has emerged as a very effective means of helping patients to self-monitor, especially those with limited movement. A substantial number of our clients have long term conditions, and so the ability to support them in several ways is of key interest to us. doc@HOME will become a cornerstone of our strategy to grow our telehealth services."

"We chose doc@HOME because it has several benefits, not least the fact that it has been developed and widely tested successfully in the UK. It has great functionality which makes it ideal for patients with different long term conditions, not just one single disease. The price of the unit is also very attractive. As well as being low cost there are no hidden extras that you find with other telehealth solutions."

Adrian Flowerday, Managing Director of Docobo, said: "RSLSTEEPER's strategy is a natural progression for the company which has a reputation for providing modern and effective healthcare solutions. RSLSTEEPER enables people to make a massive difference to their lives. By enabling them to use doc@HOME, it gives them even greater flexibility to decide how they should support themselves."

The versatility of the Doc@HOME telehealth service enhances the management and support of patients with chronic disease, short and long term monitoring needs, and for episodes of pre and post hospital care provision.

Use of Doc@HOME has demonstrated substantial cost reductions, providing the potential for year on year services funded through the utilisation of freed up resource.

About Docobo
Docobo Ltd is a UK healthcare solutions provider, involved in the management and prevention of Long Term Conditions (LTCs, also known as chronic diseases). The company is at the forefront of the development of systems for the management of patients with Long Term Conditions in their own homes.

The company has developed a remote monitoring service for LTC's, called doc@HOMEĀ®, and is developing a focused range of related services and products to expand its portfolio. This telehealth service offers care providers with an integrated low cost solution for the collection, management and analysis of essential patient related data, and permits efficient interaction between clinicians and patients at home. For further information, please visit www.docobo.co.uk

About RSLSTEEPER
Originally founded in 1921, RSLSTEEPER is now the largest supplier of Prosthetic and Orthotic patient care services in the United Kingdom, providing both manufacturing and clinical services to the UK Government National Health Service. For further information, please visit www.rslsteeper.co.uk

Most Popular Now

Unlocking the 10 Year Health Plan

The government's plan for the NHS is a huge document. Jane Stephenson, chief executive of SPARK TSL, argues the key to unlocking its digital ambitions is to consider what it...

Alcidion Grows Top Talent in the UK, wit…

Alcidion has today announced the addition of three new appointments to their UK-based team, with one internal promotion and two external recruits. Dr Paul Deffley has been announced as the...

AI can Find Cancer Pathologists Miss

Men assessed as healthy after a pathologist analyses their tissue sample may still have an early form of prostate cancer. Using AI, researchers at Uppsala University have been able to...

AI, Full Automation could Expand Artific…

Automated insulin delivery (AID) systems such as the UVA Health-developed artificial pancreas could help more type 1 diabetes patients if the devices become fully automated, according to a new review...

New Training Year Starts at Siemens Heal…

In September, 197 school graduates will start their vocational training or dual studies in Germany at Siemens Healthineers. 117 apprentices and 80 dual students will begin their careers at Siemens...

How AI could Speed the Development of RN…

Using artificial intelligence (AI), MIT researchers have come up with a new way to design nanoparticles that can more efficiently deliver RNA vaccines and other types of RNA therapies. After training...

MIT Researchers Use Generative AI to Des…

With help from artificial intelligence, MIT researchers have designed novel antibiotics that can combat two hard-to-treat infections: drug-resistant Neisseria gonorrhoeae and multi-drug-resistant Staphylococcus aureus (MRSA). Using generative AI algorithms, the research...

AI Hybrid Strategy Improves Mammogram In…

A hybrid reading strategy for screening mammography, developed by Dutch researchers and deployed retrospectively to more than 40,000 exams, reduced radiologist workload by 38% without changing recall or cancer detection...

Penn Developed AI Tools and Datasets Hel…

Doctors treating kidney disease have long depended on trial-and-error to find the best therapies for individual patients. Now, new artificial intelligence (AI) tools developed by researchers in the Perelman School...

Are You Eligible for a Clinical Trial? C…

A new study in the academic journal Machine Learning: Health discovers that ChatGPT can accelerate patient screening for clinical trials, showing promise in reducing delays and improving trial success rates. Researchers...

New AI Tool Addresses Accuracy and Fairn…

A team of researchers at the Icahn School of Medicine at Mount Sinai has developed a new method to identify and reduce biases in datasets used to train machine-learning algorithms...

Global Study Reveals How Patients View M…

How physicians feel about artificial intelligence (AI) in medicine has been studied many times. But what do patients think? A team led by researchers at the Technical University of Munich...